| Literature DB >> 29606001 |
Ke-Bin Huang1, Feng-Yang Wang2, Xiao-Ming Tang1, Hai-Wen Feng1, Zhen-Feng Chen1, Yan-Cheng Liu1, You-Nian Liu2, Hong Liang1,2.
Abstract
Agents inducing both apoptosis and autophagic death can be effective chemotherapeutic drugs. In our present work, we synthesized two organometallic gold(III) complexes harboring C^N ligands that structurally resemble tetrahydroisoquinoline (THIQ): Cyc-Au-1 (AuL1Cl2, L1 = 3,4-dimethoxyphenethylamine) and Cyc-Au-2 (AuL2Cl2, L2 = methylenedioxyphenethylamine). In screening their in vitro activity, we found both gold complexes exhibited lower toxicity, lower resistance factors, and better anticancer activity than those of cisplatin. The organometallic gold(III) complexes accumulate in mitochondria and induce elevated ROS and an ER stress response through mitochondrial dysfunction. These effects ultimately result in simultaneous apoptosis and autophagy. Importantly, compared to cisplatin, Cyc-Au-2 exhibits lower toxicity and better anticancer activity in a murine tumor model. To the best of our knowledge, Cyc-Au-2 is the first organometallic Au(III) compound that induces apoptosis and autophagic death. On the basis of our results, we believe Cyc-Au-2 to be a promising anticancer agent or lead compound for further anticancer drug development.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29606001 DOI: 10.1021/acs.jmedchem.7b01694
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446